Information om | Engelska ordet CD22


CD22

Antal bokstäver

4

Är palindrom

Nej

1
CD

10

4

10

3
CD
DC


Sök efter CD22 på:



Exempel på hur man kan använda CD22 i en mening

  • These patients were treated with the recombinant immunotoxin which targets the CD22 cell surface receptor on these leukemic cells.
  • Siglecs have been characterized into two distinct groups: the first and highly conserved-across-mammals group composed of Sialoadhesins, CD22, MAG, and Siglec-15, and a second group comprising Siglecs closely related to CD33.
  • The medication consists of a humanized monoclonal antibody against CD22 (inotuzumab), linked to a cytotoxic agent from the class of calicheamicins called ozogamicin.
  • In mice, it has been shown that CD22 blockade restores homeostatic microglial phagocytosis in aging brains.
  • In B-PLL patients there is strong expression of surface immunoglobulin – a membrane-bound form of an antibody, b-lymphocyte surface antigens CD19, CD20, CD22, CD79a and FMC7, and weak expression of CD5 and CD23.
  • The DLBCL cells have found to express B-cell antigens such as CD19, CD20, and CD22 as well as the transcription factors PAX5, BOB.
  • The toxin is activated intracellularly, by the low pH of the lysosome into which the entire protein was internalized via the CD22 receptor.
  • Epratuzumab (a CD22 Mab) acts using trogocytosis to transfer CD22 and other B-cell proteins from B cells to effector cells.
  • He currently has 401 total publications and 25 issued patents relating to B cells and their products, including CD19, CD20, CD22, CD83, and L-selectin.
  • Reed-Sternberg and Hodgkin (RSH) cells are rarely seen, and immunohistochemistry shows a different pattern on the malignant cells; RSH cells typically express CD15 and CD30, whereas LP cells lack expression of these markers, but express B cell markers like CD20, CD22, and CD79a and also express the common leukocyte antigen CD45, which is uncommon on RSH cells.
  • The RICG was successful in producing a range of recombinant immunotoxins based on the monoclonal antibodies 4KB128 and OKT10 targeting CD22 and CD38, respectively on normal and malignant lymphoid cells.


Förberedelsen av sidan tog: 518,65 ms.